mecamylamine has been researched along with Cognitive Decline in 1 studies
Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hahn, B | 1 |
| Harvey, AN | 1 |
| Concheiro-Guisan, M | 1 |
| Huestis, MA | 1 |
| Ross, TJ | 1 |
| Stein, EA | 1 |
1 other study available for mecamylamine and Cognitive Decline
| Article | Year |
|---|---|
Nicotinic receptor modulation of the default mode network.
Topics: Adult; Brain; Cognition; Cognitive Dysfunction; Default Mode Network; Female; Gyrus Cinguli; Humans; | 2021 |